Israel Englander’s Kezar Life Sciences KZR Stock Holding History

Israel Englander’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-9,000	Closed	-$775K	–	6816
2022 Q3	$775K	Sell	9,000 -23,240	-72%	-$2.26M	﹤0.01%	4557
2022 Q2	$2.67M	Buy	32,240 +27,240	+545%	+$2.4M	﹤0.01%	3409
2022 Q1	$831K	Buy	+5,000	New	+$718K	﹤0.01%	4708

Israel Englander's KZR Position: Q2 2026 in Review

Israel Englander sold out of Kezar Life Sciences (KZR) in Q2 2026, closing a stake of 142,050 shares — an estimated $1.05M sold.

Israel Englander first reported a position in KZR in Q2 2018 and held it in 28 quarters. The position peaked at $25.5M in Q3 2022. 0 funds tracked by Wall St. Rank hold KZR as of Q2 2026.

Israel Englander reported no remaining Kezar Life Sciences position as of Q2 2026 after selling out during the quarter.
Israel Englander sold 142,050 Kezar Life Sciences shares in Q2 2026, an estimated $1.05M.
Israel Englander first reported a position in Kezar Life Sciences in Q2 2018 and held it in 28 quarters.
Israel Englander's Kezar Life Sciences position peaked at $25.5M in Q3 2022.
0 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.